Pathway analysis interprets metabolite changes through biochemical pathways, helping researchers understand metabolic regulation, disease mechanisms, pathway disruption, and systems-level biological function.
Pathway analysis transforms metabolite measurements into biological interpretation. Rather than viewing metabolites as isolated molecules, pathway analysis connects them to biochemical routes, enzyme activity, cellular regulation, disease mechanisms, and physiological state.
At PanorOmics, pathway analysis is presented as a core metabolomics research area: the interpretive layer that connects metabolite profiling, metabolic phenotyping, disease biomarkers, systems biology, and multi-omics integration.
Connecting metabolites to biochemical pathways to understand cellular metabolism, disease mechanisms, and biological regulation.
Identifying pathways that are overrepresented among altered metabolites across conditions, tissues, or disease states.
Interpreting metabolites through biochemical networks, pathway topology, enzyme activity, and systems-level relationships.
Combining metabolomics with genomics, transcriptomics, proteomics, lipidomics, and clinical data to understand pathway-level biology.
Liquid chromatography mass spectrometry used to detect metabolites that can be mapped to biochemical pathways.
Gas chromatography mass spectrometry used to measure small molecules involved in central carbon metabolism, amino acid metabolism, and organic acid pathways.
Reproducible metabolite measurement technology used to study pathway-level metabolic patterns.
Resources such as KEGG, Reactome, HMDB, and MetaboAnalyst support metabolite annotation and pathway interpretation.
Machine learning and computational methods that support pathway prediction, network interpretation, and metabolic signature discovery.
Analyzes pathways such as glycolysis, the TCA cycle, pentose phosphate pathway, and energy metabolism.
Studies amino acid pathways involved in biosynthesis, signaling, nitrogen balance, and disease-associated metabolic changes.
Connects metabolite patterns with lipid metabolism, membrane biology, inflammation, and metabolic disease.
Interprets metabolites involved in oxidative stress, antioxidant defense, mitochondrial function, and cellular damage.
Identifies altered metabolic pathways associated with cancer, diabetes, cardiovascular disease, neurodegeneration, and immune disorders.
Combines metabolite data with genes, transcripts, proteins, enzymes, and clinical phenotypes to model biological systems.
Related metabolomic approaches such as metabolite profiling, metabolic phenotyping, and disease biomarker discovery are explored across the Metabolomics Research Center.
Foundational metabolic pathways such as glycolysis and the citric acid cycle established the framework for understanding cellular metabolism.
Biochemical testing linked metabolite abnormalities to pathway dysfunction, inherited metabolic disease, and clinical phenotypes.
High-throughput metabolomics expanded pathway analysis from individual metabolites to system-wide biochemical patterns.
Metabolic databases and pathway tools improved metabolite annotation, pathway mapping, and biological interpretation.
Network-based approaches connected metabolites with enzymes, pathways, disease mechanisms, and systems biology.
Integrated omics approaches connect metabolic pathways with genomic, transcriptomic, proteomic, lipidomic, and clinical data.
AI increasingly supports metabolic pathway prediction, pathway enrichment, network modeling, and systems-level interpretation.
Continue exploring the Metabolomics Research Center.
Continue exploring the Metabolomics Research Center.
Continue exploring the Metabolomics Research Center.